CenterVue SpA

What CenterVue SpA does

CenterVue SpA is an Italian medical device company headquartered in Padova, Italy, founded in 2008 and operating as a wholly-owned subsidiary of the Finnish conglomerate Revenio Group under the iCare brand. It manufactures ophthalmic diagnostic devices spanning four product families: confocal TrueColor fundus imaging systems (DRSplus, EIDON, EIDON AF, EIDON FA), automated perimetry with active retinal tracking (COMPASS), microperimetry (MAIA), and a portfolio of rebound tonometers (ST500, IC100, IC200, HOME2). Its underlying technology rests on patented rebound tonometry, confocal-based fundus imaging, TrueColor imaging, and active retinal tracking, supported by over 300 clinical studies validating measurement reliability.

The company's revenue model combines hardware sales of capital diagnostic equipment to ophthalmologists, optometrists, hospitals, and clinics with recurring revenue from proprietary disposable probes (TP01, TP022) and an emerging software layer (iCare CLINIC, iCare ILLUME for AI-powered screening, iCare RETCAD for AI retinal image analysis, iCare OCULO for teleophthalmology). Distribution runs through Revenio's global network — direct subsidiaries in the US, Australia, and China supplemented by qualified local distributors elsewhere — with quote-based pricing under multi-year arrangements.

CenterVue's strategic positioning has shifted toward integrated platform play following the iCare-Visionix partnership, which combines complementary portfolios into a turnkey eye-care solutions provider spanning diagnostics, imaging, refraction, OCT, software, and connected workflows. The company serves a horizontal customer base across primary eye care, secondary clinical settings, and screening programs, with growing emphasis on AI-enabled screening workflows and patient self-monitoring use cases.

Name

CenterVue SpA

Legal name

CenterVue SpA

Website

https://centervue.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

CenterVue SpA, an Italian subsidiary of Revenio Group operating under the iCare brand, manufactures ophthalmic diagnostic devices — confocal TrueColor fundus imaging systems, perimeters, microperimeters, and rebound tonometers — and AI-enabled screening software for eye care professionals, hospitals, and clinics worldwide.

Ownership category

akta.pro rank

Product category

Ophthalmic Diagnostic Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Ophthalmic Goods Manufacturing (339115)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Vision & Ophthalmic Diagnostic Centers (Optometry/OCT/Retinal Imaging) (HLAFAKAI)

akta.pro secondary industry

Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN)

Keywords

• Ophthalmic diagnostic devices
• Fundus imaging systems
• Rebound tonometry
• Automated perimetry
• Retinal image analysis

Headquarters

HQ city

Padova

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Ophthalmic Diagnostic Devices: CenterVue manufactures and sells ophthalmic diagnostic equipment including fundus imaging systems, perimeters, and microperimeters. Revenue is generated through device sales to eye care professionals, hospitals, and clinics worldwide.
2. Software Solutions: iCare software solutions including iCare CLINIC for tonometer data, iCare ILLUME for screening, iCare RETCAD AI-powered retinal image analysis, and iCare OCULO for teleophthalmology. These may generate recurring software revenue.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels6 records

Core offering

CenterVue SpA manufactures ophthalmic diagnostic devices under the iCare brand, including confocal TrueColor fundus imaging systems, automated perimeters and microperimeters, and patented rebound tonometers. The portfolio is complemented by software solutions for tonometer data management (iCare CLINIC), AI-powered retinal image analysis (iCare RETCAD), AI-driven screening (iCare ILLUME), and teleophthalmology (iCare OCULO). Products are sold to eye-care professionals, hospitals, and clinics worldwide through qualified distributors and regional subsidiaries.

Product overview

CenterVue SpA is a company under Revenio Group that represents the iCare brand. It operates as a platform-plus-modules architecture offering ophthalmic diagnostic solutions. The portfolio includes: fundus imaging systems (DRSplus, EIDON, EIDON AF, EIDON FA) using confocal-based TrueColor technology; perimetry and microperimetry devices (COMPASS, MAIA); rebound tonometers (ST500, IC200, IC100, HOME2); and software solutions (CLINIC, ILLUME, RETCAD AI-powered analysis, OCULO teleophthalmology). CenterVue SpA is the legal manufacturer of DRSplus, COMPASS, EIDON, EIDON AF, EIDON FA, EIDON UWF Module, DRS, MAIA, S-MAIA, iCare ALTIUS CW and iCare RETCAD.

Differentiator

Problem solved

Functional benefit

Brands

• iCare: Ophthalmic diagnostics brand under Revenio Group, encompassing fundus imaging systems, perimeters, microperimeters, tonometers, and clinical software solutions including AI-powered retinal image analysis.

Products and services

• iCare DRSplus Confocal fundus imaging device intended for optician shops, general practitioners, and diabetic clinics, part of the iCare confocal TrueColor imaging portfolio.
• iCare EIDON Confocal TrueColor fundus imaging system capturing ultra-high-quality, detail-rich retinal images from posterior pole to periphery for ophthalmologists and eye-care specialists.
• iCare EIDON AF Autofluorescence variant of the iCare EIDON fundus imaging system providing enhanced diagnostic imaging capabilities for ophthalmic use.
• iCare EIDON FA Fluorescein angiography module for the iCare EIDON fundus imaging system enabling enhanced diagnostics of retinal and choroidal vascular diseases.
• iCare COMPASS Automated perimeter that combines visual field testing, real-time retinal tracker-based fixation loss correction, and non-mydriatic confocal fundus imaging in a single exam for glaucoma and retinal disease assessment.
• iCare MAIA TrueColor confocal microperimeter combining mesopic microperimetry, visual sensitivity analysis, real-time retinal tracker fixation correction, and non-mydriatic confocal infrared and TrueColor fundus imaging in a single exam.
• iCare ST500 Slit lamp-mounted rebound tonometer providing gentle intraocular pressure measurements without the need for topical anesthesia, fluorescent dye, disinfection, or calibration.
• iCare IC200 Hand-held, battery-operated rebound tonometer providing quick and reliable intraocular pressure measurements using iCare's patented rebound technology.
• iCare IC100 Hand-held, battery-operated rebound tonometer designed for easy IOP measurement with minimal operator training.
• iCare HOME2 Self-tonometer for patient use at home, enabling patients to monitor their own intraocular pressure for glaucoma management.
• iCare CLINIC Clinical software solution for managing tonometer data, providing digital clinical tools that improve efficiency and quality in eye-care practice.
• iCare ILLUME AI-driven screening software solution providing fast, fully automated retinal imaging and processing to support higher screening throughput and a more focused, controlled referral flow.
• iCare RETCAD AI-powered retinal image analysis software that supports detection of eye diseases such as diabetic retinopathy, geographic atrophy, and age-related macular degeneration (AMD).
• iCare OCULO Teleophthalmology platform enabling remote eye-care consultations and diagnostics across distributed care settings.
• iCare TP01 Probes Disposable probes used as consumables with iCare rebound tonometers for intraocular pressure measurement.
• iCare TP022 Probes Disposable probes used as consumables with iCare rebound tonometers for intraocular pressure measurement.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Partnerships

One partnership is on record.

• VisionixcoreStrategic or Co-development PartneriCare and Visionix have officially joined forces to create a leading turnkey solutions provider for the global eye care market. The combination brings together highly complementary businesses, expanding the portfolio to span diagnostics, imaging, refraction, OCT, software and connected workflow solutions.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Tomey Corporation: Tomey is a Japanese ophthalmic diagnostics maker with a portfolio of OCT, perimetry, specular microscopy, and fundus imaging products targeting similar clinical specialties and customers as CenterVue.
• Nidek: Nidek is a Japanese manufacturer of ophthalmic diagnostic devices including fundus cameras, perimeters, OCTs, and tonometers, overlapping with CenterVue's imaging and glaucoma-diagnostic portfolio.
• Visionix (Lumibird): Visionix is iCare's newly announced strategic partner under Revenio and a direct peer in refraction, OCT, and connected workflow solutions. The partnership makes it an especially close comparison point for the combined portfolio.
• Optos (Nikon): Optos, part of Nikon, makes ultra-widefield retinal imaging devices (Daytona, California) used for diabetic retinopathy and AMD screening. It competes directly with CenterVue's EIDON UWF and DRSplus fundus systems.
• Kowa Optimed: Kowa Optimed produces fundus cameras and ophthalmic diagnostic instruments, including the non-mydriatic cameras that compete directly with CenterVue's DRSplus and EIDON family.
• Haag-Streit Group: Haag-Streit manufactures ophthalmic diagnostic and imaging equipment (slit lamps, perimeters, OCT) serving the same eye-care professional and hospital segments that CenterVue targets.
• Heidelberg Engineering: Heidelberg Engineering is a direct peer in ophthalmic diagnostic imaging, specializing in confocal laser scanning (Spectralis OCT), fundus imaging, and perimetry. Like CenterVue, it serves retina and glaucoma specialists globally with high-end diagnostic devices.
• Topcon Healthcare: Topcon is a direct peer offering fundus cameras, OCT, and screening solutions (incl. AI-based retinal screening). It targets the same ophthalmologist and optometrist customer base with a similarly broad diagnostic portfolio.

Broad incumbents

• Carl Zeiss Meditec: Zeiss Meditec is a broad incumbent offering OCT, fundus imaging, perimetry, IOLs, and surgical microscopes. It competes head-to-head in imaging diagnostics and has substantially larger R&D and global sales infrastructure than CenterVue.
• Revenio Group (parent): Revenio Group is CenterVue's publicly-listed parent and the umbrella for the iCare ophthalmic-diagnostics franchise. As a same-group peer, it is directly comparable in business model, customer base, and product scope.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/c/icareworld
• LinkedInlinkedin.com/company/centervue-spa
• Xx.com/CenterVue

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CenterVue SpA